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Epidemiologic Approaches to Assessing
Human Cancer Risk from Consuming
Aquatic Food Resources from Chemically
Contaminated Water
by David Ozonoff* and Matthew P. Longneckert
Epidemiologic approaches to human cancer risk fom nung fish from contaminated waters must con-
front the problems oflong latency and rrity ofthe end point (cancer). The lateIcy prblem makes deter_nation of diet
history more difficult, while the low frequency ofcancer as an end point reduces the satistcl power ofthe study. These
factors are dissed in relation to the study desig most co y emplyed in epideogy. It is sted that the
use ofbiomarkers for t is may be useful tomige the difficuly ofdeerngepsure, while the use
ofmoreprnt and timely end points, such as carcinogen-DNA adducts or oncogene proteins, may make the latency
and rarity problems more tractable.
Introduction
Cancer is the second leading cause ofdeath in the U.S., claim-
ing more than 1000 lives a day. Cancer is among a small set of
dread diseases that claim special public attention because of
deep-seated societal values, anxieties, and attitudes (I). The ap-
pearance ofcancer among feral fish populations is alarming not
only because it may be an indication ofa seriously compromised
aquatic habitat but also because of real or imagined conse-
quences for the human population in the same food chain. In this
paper, we discuss the use ofepidemiologic techniques to study
the effect on human cancer risk of consuming fish or shellfish
from such aquatic environments.
Epidemiologic Approach
Our knowledge ofharmful effects ofenvironmental pollutants
comes from three sources: clinical case descriptions, tox-
icological experiments, and epidemiological studies. For our
purposes, the distinguishing characteristic of a toxicological
study is the fact that it is an experiment, i.e., the investigator
manipulates the independent variable, exposure, and observes
the effect on some physiologic or pathophysiologic measure
under controlled conditions. Environmental epidemiology, on
the other hand, is an observational, not an experimental, science.
The environmental epidemiologist finds a natural experiment oc-
curring in the laboratory ofthe real world, observes its outcome,
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and then arranges the observations in a manner that produces the
most information.
Toxicology and epidemiology are naally complementary in
the information they produce. As an experimental science, with
observations made under controlled conditions, toxicological
results usually have high internal validity, i.e., when properly
designed they provide good and relatively unambiguous answers
to the precisely framed questions of the experiment. Unfor-
tunately, they may also be quite low in external validity, i.e.,
generalizability or extension to situations differing from the exact
conditions of the experiment. The problems of extrapolating
from rodents to humans or from high dose to low dose are both
problems ofpoor or uncertain external validity.
Epidemiological experiments, by contrast, often have low in-
ternal validity. Because we are constrained to observe unplanned
events in a setting that shares some but not all of the character-
istics ofa controlled experiment, we are often left with multiple,
alternative explanations for the outcome ofour unintended exper-
iment. The results, however, by their natures are highly general-
izable, as they pertain to humans living under natural conditions.
The very nature ofthe epidemiologic enterprise imposes con-
straints on the kinds ofproblems that can be effectively and ef-
ficiently addressed by this method. It is our task here to discuss
epidemiologic approaches to the question before this conference
in the light of these constraints and to suggest some possible
strategies to overcome them.
Epidemiologic Study Design
Epidemiologic study design is the process of finding and
systematically observing a natural experiment. There are three
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principal varieties of study design in common use, along with
various hybrids of the main types (2).
The most familiar design, because of its similarity to the
laboratory experiment, is the cohort or follow-up study. In this
method, two groups of individuals differing in exposure are
observed for a period oftime and then compared with respect to
their disease experience. Ifthe two groups differed only in terms
of exposure then the distinction between an observational study
and a laboratory experiment would be subtle. Unfortunately, in
most situations the two groups differ in many other ways as well,
and these disparities must be minimized in the study design and
in the analysis.
The second principal design is the case-control study. Here a
group of individuals with a particular disease (the cases) are
compared to a group ofindividuals without the disease (the con-
trols) to see if their prior exposures differ. For this type of study
to be valid the disease process must not influence the informa-
tion on exposure. In the past, such designs were calledrop-
tive studies, although now case-control or case-refrent study is
the preferred terminology. In both cohort and case-control
studies, it is the exposure prior to disease that is considered, con-
sistent with a cardinalmle ofcausalitythat cause precedes effect.
In the thirdtype of study design, the cross-sectional study,
disease and exposure status are determined at a single and con-
current point in time. This is appropriate when the exposure is
some trait or characteristic that can plausibly be held to precede
the development of the disease (e.g., blood type). In many in-
stances, however, when comparing the prevalence of symptoms
in an exposed group to that in a suitable unexposed group, one
may be uncertain if a difference in Wmptom prevalence preceded
the exposure. Nonetheless, compared to cohort or case-control
studies, cross-sectional studies are less cosdy and easier to carry
out and when properly designed and interpreted can yield very
useful infornation.
A variant of the cross-sectional study is the ecological or
geographic correlation study. Here the disease experience of
populations in geographic regions that differ in some important
exposure characteristic are compared., A difficulty with such
studies is that there are usually many other differences between
the populations besides the particular characteristic that
prompted the comparison. An example would be a comparison
of cancer rates between seaport populations and nonseaport
populations based on the assumption thatpeople in seaport areas
consume more locally caught seafood. Seaport cities are usually
industrial cities, however, and the circumstances that con-
taminate a harbor, river, or lake might also expose the popula-
tion tirough thedrinking water, the air, or in the workplace.
Moreover, the industrial workforce, with its characteristic
demographic makeup andlifestyle (diet andsmoking, for exam-
ple) may have no comparable counterpart in nonseaport popula-
tions. Hence, both the population and critical elements of the
enviroument might differ in addition to any difference due to
consumption of locally caughtseabod.
Regardless of design, a knowledge of the statistical power of
the study isimportant tointerpretation of results. Statistical
power is the ability to show with confidence that a true efect, as
opposed to one that occurred by chance, is present. Several fac-
tors detnnine the statistical power ofan epidemiologic study, in-
cluding the magnitude ofthe effect understudy, the prevalence
of exposure in the population, the fiequency with which the
disease under study occurs, and the number of subjects. The
relative importance of these factors will vary according to the
type of study. If the disease of interest is rare, often a case-control
design is used, but if the exposure is also uncommon then the
case-control study will have little power. Similarly, if exposed
and unexposed populations can be assembled for a cohort study
but few cases ofthe disease of interest occur during the observa-
tion period, then this approach too will have little power. Low
power means that unless the association of the disease with ex-
posure is strong, it is unlikely to be statistically demonstrable.
For example, assume that exposure to fish containated with
a potent cause of liver cancer could be measured with perfect ac-
curacy. If 10% ofthe population ofBoston ate enough fish to have
their risk of liver cancer increased by 50%, for a study to have
at least a 90% chance of detecting this increase we would have
to wait morethan 10 years for enough cases of liver cancer to ac-
crue before we could undertake a case-control study.
Cancer Epidemiology and
Consumption of Fish from
Contaminated Water
For long latency diseases, like cancer, where the development
of a solidtumor is usually in excess of 15 to 20 years after ex-
posure to a carcinogen, information must be available over a
significandy long period of time. Thus, for a cohort study we
must either wait several decades for the disease to develop or
assemble a decades-old cohort with ascertained historical ex-
posure and trace them to the present. Similarly, fora case-control
design, we must be able to ascertain exposure in our cases and
controls at a time decades before diagnosis of the disease.
How well can we determine for each individual how much of
the residue-laden fish he or she consumed 20 years ago? There
are two problems here. The first is to determiine how much fish
an individual consumed 20 years prior, the second to determine
if the individual consumed contminated fish.
Food intake is recalled with less than perfect accuracy. Most
ofus have difficultyremembering whatwe ate in the very recent
past, much less 20 years ago. However, we can determine broad
pattrns of food consumption (dietary habits), and dietaryrecall
methods have been successfully employed to detect rather sub-
tle food and nutrient effects. We wi theref rephrase the ques-
tion as: How well is fish intake measured relative to other foods?
In four studies, the reproducibility or validity of question-
naires regarding fish intake have been examined. Thompson
et al. (3) resurveyed subjects after 15 years and found that,
compared to other foods, fish intake was recalled fairly ac-
curately. In this study the frequency of fish consumption was
divided into eight categories; about 45% of subjects chose the
same category at baseline and whenthwy recalled their intake
15 years later. Jensen et al. (4) also resurveyed subjects after
approximately the same length of time. This group found that
fish consumption was recalled more accuratelythanmost other
fiods (the Spearman correlation coefficient between the amount
of fish consumed ateachofthetwo detrminations was 0.41). Jain
et al. (5) eamined the correlation between diet records and diet
histories covering the same recent period oftime. The intake of
fish was reported about as accurately as the intake ofodter foods
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Spearman coefficient for fish, 0.62, for shellfish, 0.72). These
studies show that fish and shellfish are remembered as well or
better than other foods and that recent diet is more clearly
recalled than diet many years earlier. By contrast, Pietinen et al.
(6) found that in Finland fish intake was reported less accurately
than most other foods. Fish intake for this population was more
than 40 g/day, which is unusually high. The fact that fish tends
to be less frequently consumed in the United States may con-
tribute to the fact that it is better remembered.
To date, these methods have not established firm associations
between fish consumption and cancer. We reviewed all
epidemiologic studies (n = 46) in which fish or shellfish intake
was examined in relation to cancer ofthe lung, large bowel, pan-
creas, breast, upper aerodigestive tract, stomach, endometrium,
owary, and prostate (7-53). We were unable to find similar studies
of sarcoma or hepatoma. Data regarding salted or smoked fish
were excluded. For cancers ofthe bowel, esophagus, stomach,
breasts and pancreas, the evidence reveals no relation between
fish intake and increased or decreased risk. For cancers of the
lung, upper aerodigestive tract (excluding esophagus), en-
dometrium, ovary, and prostate, results were inconsistent and
there was an insufficient number of studies on which to base a
generalization. Thus, at this time the epidemiologic evidence
does not support an association, either detrimental or beneficial,
between fish intake and cancer risk.
The second important question in any study of fish consump-
tion from contaminated waters concerns the extent to which the
source of the recalled diet can be determined. This depends on
the likelihood that the individual knows and can recall the source
(e.g., a recreational or commercial fisherman who habitually
consumed a portion of his catch) or the possibility that fish or
seafood consumed in a particular geographic location will have
a source that can be determined.
To illustrate the first possibility, one might take advantage of
the fact that the Commonwealth ofMassachusetts issues a special
license for recreational lobstermen. Some 12,000 of these
licenses have been issued since 1972. One could imagine
assembling a cohort of such individuals who are likely to know
the source ofat least some ofthe shellfish they have eaten. Either
the lobstermen as a whole could be considered exposed and a
follow-up done with cancer registry or mortality data, or an at-
tempt could be made to contact them, take a dietary history, and
subsequently follow them for an appropriate period ofobserva-
tion. The latter option, although more expensive, would permit
an exposure categorization to be made internal to the cohort,
allowing comparisons solely within the group of lobstermen.
Recently, Jones et al. drew a 1% random sample (n = 1600) of
1984 fishing license holders in Wisconsin (54). Fishing and fish
consumption were determined by questionnaire, and blood levels
of DDE (a metabolite of DDT) and polychlorinated biphenyls
(PCBs) were determined. Although response rate was only 50%,
the feasibility of the method was clearly demonstrated.
The precise source of fish and shellfish in a particular geo-
raphic locality is even more difficult to determine. Even if it
could be demonstrated thatmost locally consumed fish were also
locally caught, there is likely to be considerable spatial variation
in the conamination of local supplies (55). The result of these
uncertainties will produce exposure misclassification with a con-
sequent reduction in the sensitivity or power of the study.
In summary, it is possible to measure fish consumption in the
past by recall methods, but as expected, the more distant the
recall required, the less reliable the data. The bias produced by
this loss in accuracy due to misclassification reduces the
statistical power of the study, making it less likely to show that
a true association is statistically significant; however, it will not
produce a spurious association.
Strategy of Biological Markers:
A Measure of Internal Dose
It is important to remember the environmental context of the
problem: exposure of a human population to substances thrugh
the food chain. Some substances that cause tumors in fish or
shellfish may notbe passed up the food chain to human popula-
tions because dty are completely metabolized or sequestered at
lower trophic levels. For example, it is likely that most
polyaromatic hydrocarbons (PAHs) do not find their way to
humans via this route (56). On the other hand, poorly degraded
and metabolized substances such as PCBs or heavy metals will
do so. It is plausible that substances that persist at the lower
trophic levels may also do so in humans, i.e., what leaves a
residue in fish will also leave a residue in people. This is a
generalization that may have some exceptions but is sound as a
basis for strategy.
This fact suggests that we obtain data on carcinogenic residues
in humans as a surrogate for data on consumption levels of con-
atminaed fish. Because we must apply this method to a relatively
large population, we need an accessible and easily obtainable
tissue. Fat and muscle biopsies are likely to be unacceptable to
many people but may be useful for validation or case-control
studies where the number of subjects is not very large. Blood,
saliva, and urine are possible sources for analysis, aldtugh most
contaminants that will find their way up the food chain will not
be easily eliminated by kidneys or salivary glands. Moreover, ob-
mining urine specimens is usually more difficult than obtaining
blood samples. Breast milk from lactating mothers also is an ap-
propriate source of material for analysis. In addition, metals may
be detected in hair and nails.
Persistent organics, such as PCBs, are best measured by fat
biopsies. In the absence of this method, blood serum levels or
milk from lactatng mothers my be used. Studies of the relation-
ship between ingestion ofPCB-conaminated fish and PCB levels
in blood serum and milk have shown that these levels do indeed
correlate with exposure (57-59). In one of the studies, a variety
offactors that might affect PCB blood levels were examined, and
it was found that age, sex, and amount of fish consumption (in
that order) were the most important (60). PCBs can also be
passed from mother to infant through the placenta or breast milk
(59,61,62). It seems to be well established that higher exposure
to PCBs means a higher blood level of PCBs. The studies that
evaluate levels after exposure ceases are not consistent, but it
appears that the higher chlorinated congeners are eliminated
much more slowly, over months to many years.
Among the toxic metals that have been found in fish and
shellfish are cadmium, chromium, copper, lead, and mercury
(63-65). Blood levels are widely used and accepted as a measure
of exposure to lead (66), and blood levels for Cr3 are elevated
after occupational exposure (67). Methyl mercury exposure
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correlates highly with levels in blood (68), but for copper and
cadmium it is unclear ifblood levels reflect exposure until frank-
ly toxic intakes are reached (69,7V.
Methyl mercury exposure also correlates well with mercury
levels in hair (71), suggesting that levels in toenails might also be
useful, especially as hair may be affected by various treatments,
such as permanent waving. Toenails are especially convenient to
collect and store. Moreover, in the U.S., toenail are usually
sheltered from the environment by shoes, making trace element
analysis less subject to interference from environmental con-
tamination. Toenail cadmium levels have been used as an ac-
curate measure of above normal exposure (M. Maclure, un-
published data), but the relation between chromium and copper
exposures and nail levels is much less well defined (68).
With the exception of lead, these trace elements can be
measured nondestructively and simultaneously by neutron ac-
tivation analysis using very limited amounts of sample (72).
While the metals themselves may not be carcinogenic, they may
serve as useful markers for exposure to organic carcinogens,
especially ifa fingerprint oftrace metals can be determined that
is characteristic ofexposure to contaminated fish or seafood. In
general, depending on which digit is sampled, nail levels reflect
body levels in the preceding 3 to 12 months. This relationship
may be especially useful in a case-control design since blood
analyses mould nwasure current body levels that might have been
affected by the disease process itself (73).
Whatever the indicator ofinternal exposure, a study that cor-
relates consumption of carcinogen-contaminated fish and
shellfish with an appropriate marker is an important part ofthe
overall strategy. It is obvious that selecting a marker will require
cooperation between laboratory scientists and epidemiologists.
Markers of Biological and
Preclinical Effect
Markers of internal exposure may alleviate some of the pro-
blems that result from exposure misclassification, but the dif-
ficulties caused by seeking end points or exposures of low fre-
quency remain. To address the problem of low frequency end
points such as cancer, either large sample sizes are required, or
another consequence of exposure, more common than cancer,
must be used. If, in addition, another appropriate end point ap-
peared earlier than cancer we could use dietary recall methods
for a shorter period and hence with more confidence.
In recent years, several techniques to measure higher
prevalence end points associated with cancer have been suggested
(74). It is believed that the earliest steps in malignant transforma-
tion by chemical agents involve covalentbinding ofthe substance
to cellular DNA. Fish sampled from PAH-conaminated areas of
the Buffalo and Detroit Rivers have elevated liver cancer rates
and have demonstrably higher levels of aromatic carcinogen-
DNA adducts (75). Detection of cellular carcinogen-DNA ad-
ducts in humans by highly specific antibodies has also been ac-
complished for a few agents and holds some promise for use as
an epidemiologic end point (76). Detection ofadducts in urine
resulting fromDNA repair processes has also been successful,
although those who excrete the adducts may arguably be at lower
risk because of their obvious DNA repair competency (77).
Chemicals that alter DNA may also alter proteins. Adducts on
readily accessible proteins such as hemoglobin or albumin have
been used as surrogates for DNA adduction. The much larger
quantity ofprotein available increases the minimum detectable
level of adduction (78).
Other end points closer to the clinical event may also prove
useful. Sister-chromatid exchanges, chromosome breaks, or in-
creases in the point mutation rate have all been suggested,
althugh they are not agent spific, nor is their relationship with
the cancer end point clear. Rcentdy, the use ofoncogene proteins
as preclinical response indicators has been advocated (74). This
technique assumes that inappropriately timed or regulated ex-
pression ofparticular cellular genes or the products ofa mutated
gene are the key events in the malignant process. In some cases,
both the genes and the products associated with human tumors
have been identified. Thus, monoclonal antibodies directed
against an abnormal gene product might be used to screen
cohorts for those individuals at highest risk ofdeveloping cancer.
The validation of this method remains to be accomplished,
however. Indeed, before any ofthese techniques can be used in
epidemiologic studies, a great deal ofwork mustbe done to docu-
ment the sensitivity and specificity ofthe methods as indicators
of either exposure or biological effect (79).
Conclusion
It is not yet possible to give a confident answer to the general
question ofwhether cancer risks are increased by consuming fish
and shellfish from chemically contminated waters, although in
particular instances we may be able to make some reasonable
judgments. As this conference illustrates, determining cancer
risk will require persistent effort from many different directions.
Because in this setting epidemiologic studies have limited power,
the extent to which they can play a role appears minimal for the
immediate future. An attempt to quantify exposure to chemical
carcinogens with biologic markers in populations consuming
relatively large quantities ofcontaminated fish or shellfish may
be a reasonable starting point.
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